Welcome to our dedicated page for Silk Road Medical news (Ticker: SILK), a resource for investors and traders seeking the latest updates and insights on Silk Road Medical stock.
Silk Road Medical (SILK) delivers innovative solutions for carotid artery disease through its clinically validated TCAR technology. This news hub provides investors and healthcare professionals with essential updates on the company’s advancements in stroke prevention and vascular surgery.
Access consolidated information on regulatory milestones, clinical trial results, and strategic partnerships that demonstrate SILK’s leadership in minimally invasive therapies. Our repository includes earnings reports, product launch announcements, and peer-reviewed study outcomes critical for evaluating the company’s market position.
Discover how SILK’s neuroprotective technologies and surgeon collaborations continue shaping vascular care standards. Bookmark this page for real-time updates on developments impacting both patient outcomes and long-term corporate growth in the medical device sector.
Silk Road Medical (Nasdaq: SILK), a medical device company dedicated to stroke risk reduction, will participate in the BofA Securities 2023 Healthcare Conference on May 10, 2023, at 4:20 p.m. PT. Interested individuals can access a live and archived webcast via the company’s website.
The company is known for its innovative approach to treating carotid artery disease through a procedure called TransCarotid Artery Revascularization (TCAR), which combines surgical neuroprotection principles with minimally invasive techniques.
For further inquiries, reach the Investor Contact at investors@silkroadmed.com.
Silk Road Medical, Inc. (Nasdaq: SILK) will release its first quarter 2023 financial results on May 9, 2023, after market close, followed by an audio webcast at 1:30 p.m. PT. The company, based in Sunnyvale, California, specializes in reducing stroke risk through its innovative TransCarotid Artery Revascularization (TCAR) procedure. This method merges surgical neuroprotection with minimally invasive techniques to address carotid artery blockages.
Interested parties can register for the conference call online and join the live or replay webcast to gain insights into the company’s financial performance and future outlook.
FAQ
What is the current stock price of Silk Road Medical (SILK)?
What is the market cap of Silk Road Medical (SILK)?
